In-Vitro Colorectal Cancer Screening Tests

Global Market Trajectory & Analytics

MCP11160

EXECUTIVE ENGAGEMENTS

POOL

4827
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

869
Interactions with Platform & by Email

PARTICIPANTS

143
Unique # Participated

VALIDATIONS

42
Responses Validated*

COMPANIES

44
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

207

PAGES

281

EDITION

8

PRICE

USD 5450

CODE

MCP11160


COMPETITIVE METRICS

COMPANY

D S N T

% *

Abbott Laboratories, Inc.

Alere, Inc.

Arocell

Beckman Coulter, Inc.

Chosen Diagnostics

Clinical Genomics Technologies Pty Ltd.

Eiken Chemical Co., Ltd.

Epigenomics AG

Hemosure, Inc.

IFLScience Limited

*Login to Participate & View Data Stacks
View 44 Companies...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for In-Vitro Colorectal Cancer Screening Tests estimated at US$879.1 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 3.5% over the analysis period 2020-2027. Fecal Occult Blood Test, one of the segments analyzed in the report, is projected to record a 3.7% CAGR and reach US$851.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biomarker Test segment is readjusted to a revised 2.8% CAGR for the next 7-year period.
The In-Vitro Colorectal Cancer Screening Tests market in the U.S. is estimated at US$237.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$233.7 Million by the year 2027 trailing a CAGR of 6.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1% and 2.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.
In the global CRC DNA Screening Test segment, USA, Canada, Japan, China and Europe will drive the 2.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$39.6 Million in the year 2020 will reach a projected size of US$47.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$156.2 Million by the year 2027, while Latin America will expand at a 3.9% CAGR through the analysis period.

SELECT PLAYERS

Abbott Laboratories, Inc.; Alere, Inc.; Beckman Coulter, Inc.; Clinical Genomics Technologies Pty Ltd.; Eiken Chemical Co., Ltd.; Epigenomics AG; Exact Sciences Corporation; Hemosure, Inc.; Novigenix SA; Quidel Corporation; Sysmex Corporation

SEGMENTS

» End-Use (Hospitals, Clinical Diagnostic Laboratories, Other End-Uses) » Segment (Fecal Occult Blood Test, Biomarker Test, CRC DNA Screening Test)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Colorectal Cancer: Symptoms, Causes & Risk Factors
Screening for Colorectal Cancer
In-Vitro Colorectal Cancer Screening Tests
Fecal Occult Blood Test
Biomarker Test
CRC DNA Screening Test
Global Market Prospects & Outlook
Fecal Occult Blood Tests Dominate Market
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Colorectal Cancer Drives Market Growth
EXHIBIT: Number of New Cancer Cases and Number of Deaths by Type of Cancer in 2020
EXHIBIT: Countries with Highest Rate of Colorectal Cancer: Age-Standardized Cases Per 100000 Population
EXHIBIT: Colorectal Cancer Rates In Men by Country
EXHIBIT: Colorectal Cancer Rates In Women by Country
Aging Demographics & Rising Prevalence of Chronic Disorders Enhance Risk of Colorectal Cancer, Necessitating Screening Tests
EXHIBIT: Global Aging Population: 65+ Individuals by Region for 2019 and 2050
EXHIBIT: Life Expectancy at Birth and at 65 Age by Region
Launch of Novel Screening Tests for Detection of Inherited Colorectal Cancer to Spur Gene Testing
Market to Benefit from Technological Advancements in Cancer Screening Techniques
R&D Investments in Development of Advanced DNA Sequencing Methods to Drive Market Opportunities
Biomarker Tests for Colorectal Cancer Screening
Molecular Markers Gain Prominence for Colorectal Cancer Screening
Rising Need for Minimally Invasive Colorectal Cancer Screening Tests Drives Demand for Genetic and DNA Biomarkers
At-Home Screening Test for Colorectal Cancer
Government Regulations & Guidelines on Cancer Screening: Potential for Growth
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Fecal Occult Blood Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Fecal Occult Blood Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Fecal Occult Blood Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Biomarker Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Biomarker Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biomarker Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for CRC DNA Screening Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for CRC DNA Screening Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for CRC DNA Screening Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Clinical Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Clinical Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Clinical Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
USA Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
China Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
France Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
UK Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
India Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for In-Vitro Colorectal Cancer Screening Tests by Segment - Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by Segment - Percentage Breakdown of Value Sales for Fecal Occult Blood Test, Biomarker Test and CRC DNA Screening Test for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for In-Vitro Colorectal Cancer Screening Tests by End-Use - Hospitals, Clinical Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for In-Vitro Colorectal Cancer Screening Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027
Total Companies Profiled: 44

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com